Show simple item record

Efficacy of follitropin-alpha versus human menopausal gonadotropin for male patients with congenital hypogonadotropic hypogonadism

dc.contributor.authorCilesiz, Nusret Can
dc.contributor.authorOrtac, Mazhar
dc.contributor.authorKadioglu, Ates
dc.contributor.authorHidir, Muhammed
dc.date.accessioned2021-03-03T12:44:01Z
dc.date.available2021-03-03T12:44:01Z
dc.date.issued2020
dc.identifier.citationOrtac M., Hidir M., Cilesiz N. C. , Kadioglu A., "Efficacy of follitropin-alpha versus human menopausal gonadotropin for male patients with congenital hypogonadotropic hypogonadism", TURKISH JOURNAL OF UROLOGY, cilt.46, sa.1, ss.13-17, 2020
dc.identifier.othervv_1032021
dc.identifier.otherav_2fccdc4e-191c-4f03-800a-eb02dde061ed
dc.identifier.urihttp://hdl.handle.net/20.500.12627/36641
dc.identifier.urihttps://doi.org/10.5152/tud.2019.19177
dc.description.abstractObjective: To compare human menopausal gonadotropin (hMG) and recombinant follicle-stimulating hormone (rFSH) with respect to successful spermatogenesis and pregnancy outcomes in patients with congenital hypogonadotropic hypogonadism (CHH).
dc.language.isoeng
dc.subjectKlinik Tıp
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectNefroloji
dc.titleEfficacy of follitropin-alpha versus human menopausal gonadotropin for male patients with congenital hypogonadotropic hypogonadism
dc.typeMakale
dc.relation.journalTURKISH JOURNAL OF UROLOGY
dc.contributor.departmentBatman Regional State Hospital , ,
dc.identifier.volume46
dc.identifier.issue1
dc.identifier.startpage13
dc.identifier.endpage17
dc.contributor.firstauthorID272610


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record